Syphilis Testing Industry Development, Key Players, and Predictions
Global syphilis testing market is anticipated to witness an exponential growth in the
forecast period. Syphilis is a sexually transmitted infection caused by the
Treponema palladium bacterium. The factors that propel the growth of the market
include increase in occurrence of syphilis, increasing incidences of syphilis,
implementation of national screening plans, rising acceptance of novel
technologies such as Darkfield microscopy, Enzyme Immunoassay (EIA) tests, and
Micro hemagglutination (MHA-TP) assay that enables improved and faster
screening results.
On the other hand, there
are factors that may hamper the growth of the market including the lack of
trained professionals, and a shortage of these experts in hospitals and
diagnostic centers. Syphilis testing market is anticipated to expand at a
significant CAGR in the upcoming period as the scope, product types, and its
applications are increasing across the globe.
The new trend gaining
drive in the market is surge in premarital screening. Premarital screening is a
fitness valuation test for soon-to-be-married couples who are tested for the
possibility of genetic diseases, transmissible diseases and infectious
diseases. The market could be explored by type, product, technology, screening
test type, and geography.
Get Sample Copy of this Report @
The market could be explored by Product as Assay/Consumables,
Instruments. The market could be explored by type as Primary Syphilis and
Secondary Syphilis. Based on technology, the market could span POC testing and
Conventional testing. The “Conventional testing” segment led the syphilis
testing market in 2017 and will continue to lead in the forecast period. The
key factors that may be attributed to the growth of the market include the
capacity of this conventional testing technology to notice several stages of
syphilis.
The market could be explored based on screening test type
as Rapid plasma reagin (RPR) test, Venereal disease research laboratory (VDRL)
test, Fluorescent treponemal antibody absorption (FTA-ABS) test, Enzyme
immunoassay (EIA) test, Treponema pallidum particle agglutination assay (TPPA),
Micro hemagglutination assay (MHA-TP), and Darkfield microscopy.
LAMEA and the Asia Pacific accounted for the major share
of the syphilis testing market in 2017 and will continue to lead in the
forecast period. The factors that could be attributed to the growth include
higher acceptance rates for technologically highly advanced screening tests,
active measures from the governments, and private associations along with the
rising consciousness for the syphilis infections largely contributed to the
growth of the market.
Some of the key players that fuel the growth of the
syphilis testing market comprise Abbott Diagnostic, Alere, Beckman Coulter,
Siemens Healthcare, and Roche Diagnostics, AccuBioTech, Becton Dickinson and
Company, Bio-Rad Laboratories, bioLytical Laboratories, Chembion Diagnostic
Systems, Diasorin, DRG International, Grifols, IBL International, MEd Mira,
Omega Diagnostics, Trinity Biotech, Ulti med Products, and ZEUS Scientific. The
leading companies are taking up partnerships, mergers and acquisitions, and
joint ventures in order to boost the inorganic growth of the industry.
Browse Related Category Market
Reports @
Comments
Post a Comment